IRIS

ARPINO, GRAZIA

ARPINO, GRAZIA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 163 (tempo di esecuzione: 0.051 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. 1.1 Articolo in rivista 2005 Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M.
Estrogen receptor-positive, progesterone receptor-negative breast cancer: correlation with growth factor receptor expression and tamoxifen resistance. 4.1 Articoli in Atti di convegno 2004 Arpino, Grazia; Weiss, H; Lee, A; Schiff, R; Osborne, Ck; Elledge, Rm
Clinical and biologic features of ER- PR- HER-2- breast cancer compared to estrogen or HER-2 driven phenotypes 4.1 Articoli in Atti di convegno 2005 Arpino, Grazia; H., Weiss; R., Elledge
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study 1.1 Articolo in rivista 2013 Carlo, Lazzaro; Roberto, Bordonaro; Francesco, Cognetti; Fabi, ; DE PLACIDO, Sabino; Marchetti, Botticelli; Pronzato, Martelli; Arpino, Grazia
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer. 1.1 Articolo in rivista 2005 Arpino, Grazia; D. R., Ciocca; H., Weiss; D. C., Allred; P., Daguerre; L., Vargas Roig; M., Leuzzi; F., Gago; R., Elledge; S. K., Mohsin
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. 1.1 Articolo in rivista 2005 Arpino, Grazia; H. L., Weiss; G. M., Clark; S. G., Hilsenbeck; C. K., Osborne
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. 1.1 Articolo in rivista 2003 Valerie Jeanne, Bardou; Arpino, Grazia; Richard M., Elledge; C., Kent Osborne; Gary M., Clark
Premalignant and in situ breast disease: biology and clinical implications. 1.1 Articolo in rivista 2005 Arpino, Grazia; Rodolfo, Laucirica; Richard M., Elledge
Predictive value of apoptosis, proliferation, and HER-2 for anthracycline chemotherapy in patients with locally advanced breast cancer 4.1 Articoli in Atti di convegno 2003 Arpino, Grazia; D. R., Ciocca; H., Weiss; P., Daguerre; L., Vargas Roig; M., Leuzzi; F., Gago; R., Elledge; S., Mohsin
Capitolo 4 - Terapia Medica 2.1 Contributo in volume (Capitolo o Saggio) 2011 G., Tortora; F., Ciardiello; Arpino, Grazia; A. R., Bianco
Triple-negative breast cancers: Biomarkers and outcomes 4.1 Articoli in Atti di convegno 2010 Malorni, L.; Shetty, P. B.; Hilsenbeck, S. G.; Rimawi, M. F.; Elledge, R. M.; De Angelis, C.; Osborne, C. K.; DE PLACIDO, Sabino; Arpino, Grazia
Health-care costs associated with breast cancer management 1.5 Abstract in rivista 2010 Cammarota, S.; Citarella, A.; Menditto, Enrica; Putignano, D.; Riegler, S.; De Luca, L.; Malorni, L.; DE PLACIDO, Sabino; Arpino, Grazia
Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy: Results from a joinpoint regression analysis. 1.1 Articolo in rivista 2013 Crispo, A; Barba, M; Malvezzi, M; Arpino, Grazia; Grimaldi, M; Rosso, T; Esposito, E; Sergi, D; Ciliberto, G; Giordano, A; Montella, M.
Gene expression profiling in breast cancer: A clinical perspective 1.1 Articolo in rivista 2013 Arpino, Grazia; Daniele, Generali; Anna, Sapino; Lucia Del, Matro; Antonio, Frassoldati; Michelino de, Laurentis; Paolo, Pronzato; Giorgio, Mustacchi; Marina, Cazzaniga; DE PLACIDO, Sabino; Pierfranco, Conte; Mariarosa, Cappelletti; Vanessa, Zanoni; Andrea, Antonelli; Mario, Martinotti; Fabio, Puglisi; Alfredo, Berruti; Alberto, Bottini; Luigi, Dogliotti
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, Chiara; Ciardiello, F; Tortora, G; D’Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; DE PLACIDO, Sabino
HER-2 amplification, EGFR expression, and tamoxifen response in ER-positive metastatic breast cancer; a SWOG study 4.1 Articoli in Atti di convegno 2002 Arpino, Grazia; S., Green; Dc, Allred; P., Ravdin; D., Lew; S., Martino; Ck, Osborne; R., Elledge
Potent inhibition of EGFR(ErbB1)/HER2 (ErbB2) pathway plus estrogen deprivation is a superior therapeutic combination in ER positive HER2-neu Over-expressing breast tumor xenografts. 4.1 Articoli in Atti di convegno 2006 M. F., Rimawi; H. L., Weiss; Arpino, Grazia; G. S., Morris; R. D., Soliz; R. M., Ward; T. M., Gilmer; C. K., Osborne; R., Schiff
Complete disappearance of ER+/HER2+ breast cancer xenografts with the combination of gefitinib, trastuzumab, and pertuzumab to block HER2 cross-talk with ER and restore tamoxifen inhibition. 4.1 Articoli in Atti di convegno 2004 Arpino, Grazia; Weiss, H; Wakeling, Ae; Osborne, K; Schiff, R.
Progesterone receptor (PgR) status provides additional information to estrogen receptor (ER) status for predicting clinical outcomes of primary breast cancer patients treated with adjuvant endocrine therapy. 4.1 Articoli in Atti di convegno 2002 V. J., Bardou; Arpino, Grazia; R. M., Elledge; G. M., Clark
Prognostic and predictive factors in breast cancer, an evidence-based medicine approach 2.1 Contributo in volume (Capitolo o Saggio) 2002 Mohsin, Sk; Bardou, Vj; Arpino, Grazia; Chamness, Gc; Allred, Dc